Question 1193 — pharmacy and medicines

Summary

Ms. Valérie Beauvais draws the attention of the Minister of Solidarity and Health to the modification of the Levothyrox formula that took place in March 2017. This medication is prescribed in France to approximately 3 million people suffering from hypothyroidism. This modification was requested by the National Medicines Safety Agency in order to improve chemical stability over time, but it seems to cause many side effects. in treated patients. A very strong concern appeared among users during the summer of 2017. In order to reassure this population and their loved ones, she asked them if she intended to initiate a comparative study of the old and new formula in order to scientifically measure these effects, taking into account a very narrow therapeutic margin.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.